Back to News
Market Impact: 0.35
Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Inches Higher
Source: 247wallst.com
Healthcare & BiotechInvestor Sentiment & Positioning
Moderna shares rose 7% to $241 as investors bought ahead of a closely followed melanoma presentation. The article provides no presentation details or clinical results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
MRNA0.35
More News
- Jio’s Record $3.2 Billion IPO Puts India’s Market Muscle to the Test
- Neoclouds Lose Silver Lining as Elice, CoreWeave Dive: Evening Briefing Americas
- Australian AI data centre operator NextDC shares shed 44% on revenue delay
- A top medical technology stock is trading at a big discount. Here's why I'm buying
- Obsessed with CoreWeave and the AI trade? You're missing out on some great stocks
- MSG Sports is splitting the Knicks and Rangers into two stocks, and history says spin-offs tend to beat IPOs